Serious Adverse Drug Reaction Research (R21)

This grant aims to support research grants that will advance the state of knowledge of serious adverse drug reactions. Applications across the spectrum of research are encouraged. 

Funding: $275,000

Duration: 2 years 

LOI (encouraged) due date: 4.9.16, 1.1.17, 1.5.17, 2.9.17, 1.1.18, 1.5.18, 1.9.18, 1.1.19, 3.5.19

Full application due date: 4.10.16, 1.2.17, 1.6.17, 2.10.17, 1.2.18, 1.6.18, 1.10.18, 1.2.19, 3.6.19